AGM Presentation Shows FY26 Revenue of INR 739 Cr and EBITDA Margin of 13.64%
The company shared the presentation made to shareholders at its 21st AGM (FY 2025-26).
- FY26 Operating Revenue
- INR 739 Cr
- FY26 EBITDA Margin
- 13.64%
- FY25 Operating Revenue
- INR 719 Cr
- Production Capacity
- 80,000 TPA across 6 manufacturing units
What was shared
Valiant Organics has made public the presentation shown to shareholders at its 21st Annual General Meeting held on 29 September 2026, covering FY 2025-26.
Financial trend shown
- FY23 operating revenue 912 INR Cr, EBITDA margin 14.58%
- FY24 operating revenue 677 INR Cr, EBITDA margin 6.20%
- FY25 operating revenue 719 INR Cr, EBITDA margin 8.59%
- FY26 operating revenue 739 INR Cr, EBITDA margin 13.64%
Revenue has recovered modestly from the FY24 low, while the EBITDA margin in FY26 is close to the FY23 level, indicating better profitability per rupee of sales than the two intervening years.
The presentation notes that following the IPO allotment at material step-down subsidiary Valiant Laboratories Limited, the stake of the company's subsidiary Dhanvallabh Ventures LLP in VLL was diluted to 46.83%; VLL ceased to be a step-down subsidiary and became an associate company with effect from 04 October 2023. Because of this, consolidated financials of previous periods are stated to be not comparable.
Operating scale
- 6 manufacturing units across 5 locations
- 5 Zero Liquid Discharge plants
- Total production capacity of 80,000 TPA
- 900+ employees
The company describes itself as one of the largest chlorophenol derivatives manufacturers globally, one of the largest domestic PNA manufacturers, among the first few domestic PAP manufacturers, one of the few commercial players in Ortho Anisidine and Para Anisidine, and a leading manufacturer of benzene derivatives.
FY26 revenue mix by chemistry
- Hydrogenation 48%
- Ammonolysis 26%
- Chlorination 20%
- Others 6%
FY26 revenue mix by end-user industry
- Dyes & Pigments 45%
- Agro Chemicals 24%
- Pharmaceuticals 21%
- Specialty Chemicals 10%
Background given: incorporated in 1984 by first generation technocrats, headquartered in Mumbai, focused on specialty chemicals with high demand and low domestic supply that are largely import-dependent. Key chemistries include chlorination, hydrogenation, ammonolysis, acetylation, sulphonation and methoxylation. Market capitalisation is stated as approximately INR 567 Cr as on 31st March 2026.
How investors may read it
This is a disclosure of information already presented to shareholders rather than a new business event. The useful takeaway is the margin improvement in FY26 alongside a slight revenue increase, and the concentration of revenue in the Dyes & Pigments segment.
Also from Valiant Organics
Company receives Rectification Order under Section 154 of the Income-tax Act; net Rs. 22,15,080 payable
1 Oct 2026
More numbers
- FY26 operating revenue739
- FY25 operating revenue719
- FY24 operating revenue677
- FY23 operating revenue912
- FY26 EBITDA margin13.64%
- FY25 EBITDA margin8.59%
- FY24 EBITDA margin6.20%
- FY23 EBITDA margin14.58%
- Market capitalisation as on 31st March 2026INR ~ 567 Cr.
- Total production capacity80,000 TPA
- Employees900+
- Dhanvallabh Ventures LLP stake in VLL after dilution46.83%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.